Antibodies as Drugs: Evolving Designs, Formats and Approaches

The conference examines innovations in antibodies as medicines. Researchers compare conventional and emerging formats, conjugates, multiple-target approaches, selective targeting and computational design, connecting advances in antibody engineering with dosing, combinations and therapeutic applications.